Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu
06/16/09   |   By

FDA Recommends Continued Use of ADHD Drugs | DC Metro Area Personal Injury Law Blog

5 stars

By Victor E. Long, Esq.

Yesterday, the Food and Drug Administration  recommended that children shouldn’t stop taking drugs that treat attention deficit hyperactivity disorder, or ADHD, despite a study showing the stimulants may be associated with sudden death.  Stimulants used to treat attention deficit hyperactivity disorder could increase the risk of sudden death in children who have no underlying heart conditions.

Popular stimulant medications used to treat ADHD in children and teens include such drugs as Shire’s Adderall and Novartis’ Ritalin. The drugs have previously been approved as both safe and effective in the treatment of ADHD in children by the FDA, and remain so despite the recent study.

For more information on drug related injuries, read about the decision of the U.S. Supreme Court on suing drugmakers over injuries from medicines approved by the government.

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top